Similar articles for PMID: 26235624

Year	Number of Results
1998	1
1999	1
2000	1
2001	1
2002	4
2003	4
2004	3
2005	2
2006	2
2007	2
2008	5
2009	1
2010	1
2011	2
2012	2
2014	6
2015	7
2016	2
2017	8
2018	5
2019	11
2020	18
2021	16
2022	16
2023	4
2024	0

1

In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector.

Zinn E, Pacouret S, Khaychuk V, Turunen HT, Carvalho LS, Andres-Mateos E, Shah S, Shelke R, Maurer AC, Plovie E, Xiao R, Vandenberghe LH. Zinn E, et al. Cell Rep. 2015 Aug 11;12(6):1056-68. doi: 10.1016/j.celrep.2015.07.019. Epub 2015 Jul 30. Cell Rep. 2015. PMID: 26235624 Free PMC article.

2

Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo.

Carvalho LS, Xiao R, Wassmer SJ, Langsdorf A, Zinn E, Pacouret S, Shah S, Comander JI, Kim LA, Lim L, Vandenberghe LH. Carvalho LS, et al. Hum Gene Ther. 2018 Jul;29(7):771-784. doi: 10.1089/hum.2017.154. Epub 2018 Mar 20. Hum Gene Ther. 2018. PMID: 29325457 Free PMC article.

3

New recombinant serotypes of AAV vectors.

Gao G, Vandenberghe LH, Wilson JM. Gao G, et al. Curr Gene Ther. 2005 Jun;5(3):285-97. doi: 10.2174/1566523054065057. Curr Gene Ther. 2005. PMID: 15975006 Review.

4

Ancestral library identifies conserved reprogrammable liver motif on AAV capsid.

Zinn E, Unzu C, Schmit PF, Turunen HT, Zabaleta N, Sanmiguel J, Fieldsend A, Bhatt U, Diop C, Merkel E, Gurrala R, Peacker B, Rios C, Messemer K, Santos J, Estelien R, Andres-Mateos E, Wagers AJ, Tipper C, Vandenberghe LH. Zinn E, et al. Cell Rep Med. 2022 Nov 15;3(11):100803. doi: 10.1016/j.xcrm.2022.100803. Epub 2022 Nov 2. Cell Rep Med. 2022. PMID: 36327973 Free PMC article.

5

Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.

Schön C, Biel M, Michalakis S. Schön C, et al. Eur J Pharm Biopharm. 2015 Sep;95(Pt B):343-52. doi: 10.1016/j.ejpb.2015.01.009. Epub 2015 Jan 20. Eur J Pharm Biopharm. 2015. PMID: 25615882 Review.

6

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.

Grimm D, Kay MA. Grimm D, et al. Curr Gene Ther. 2003 Aug;3(4):281-304. doi: 10.2174/1566523034578285. Curr Gene Ther. 2003. PMID: 12871018 Review.

7

Adeno-associated virus (AAV) vectors in cancer gene therapy.

Santiago-Ortiz JL, Schaffer DV. Santiago-Ortiz JL, et al. J Control Release. 2016 Oct 28;240:287-301. doi: 10.1016/j.jconrel.2016.01.001. Epub 2016 Jan 12. J Control Release. 2016. PMID: 26796040 Free PMC article. Review.

8

Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.

Grimm D, Büning H. Grimm D, et al. Hum Gene Ther. 2017 Nov;28(11):1075-1086. doi: 10.1089/hum.2017.172. Epub 2017 Aug 23. Hum Gene Ther. 2017. PMID: 28835125 Review.

9

An Alternate Route for Adeno-associated Virus (AAV) Entry Independent of AAV Receptor.

Dudek AM, Pillay S, Puschnik AS, Nagamine CM, Cheng F, Qiu J, Carette JE, Vandenberghe LH. Dudek AM, et al. J Virol. 2018 Mar 14;92(7):e02213-17. doi: 10.1128/JVI.02213-17. Print 2018 Apr 1. J Virol. 2018. PMID: 29343568 Free PMC article.

10

Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.

Liu Y, Siriwon N, Rohrs JA, Wang P. Liu Y, et al. Curr Pharm Des. 2015;21(22):3248-56. doi: 10.2174/1381612821666150531171653. Curr Pharm Des. 2015. PMID: 26027561 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year